Delta-9-THC can stay detectable in your body anywhere from a single day to well over a month, depending mainly on how often you use it and which type of drug test you face. A one-time user might clear a standard urine screen in a few days, while a daily smoker can remain positive for weeks after quitting. That spread is not a vague hedge; it reflects the unusual way THC behaves in your body, storing itself in fat tissue and slowly trickling back into your bloodstream long after the high has worn off.
Why THC Lingers Longer Than Most Drugs
After you inhale or swallow THC, your liver converts most of it into two key byproducts: an active metabolite called 11-OH-THC and an inactive one called THC-COOH (also written as 11-nor-9-carboxy-THC).1PubMed Central. Mechanisms of Action and Pharmacokinetics of Cannabis THC-COOH is the molecule most urine tests actually look for. Unlike water-soluble drugs that your kidneys flush out quickly, THC is fat-soluble. It dissolves into adipose (fat) tissue throughout your body and sits there, releasing back into your blood in small amounts over days or weeks. This slow-release reservoir is the core reason clearance times are so unpredictable and why heavy users test positive far longer than occasional ones.
Urine Tests
Urine screening is by far the most common form of drug testing for employment and legal purposes, and it is the test most people are worried about. The standard federal workplace cutoff is 50 ng/mL on an initial immunoassay screen, with a confirmatory test at 15 ng/mL for THC-COOH. The cutoff matters enormously because lowering it extends the detection window.
For infrequent users, research shows detection windows that are shorter than many people assume. In a controlled-dose study, average detection times at the 50 ng/mL cutoff were under one day after a low dose and under two days after a higher dose. Even at a more sensitive 20 ng/mL cutoff, detection ranged from about one to five days after the low dose and three to six days after the high dose.2Journal of Analytical Toxicology. Detection Times of Marijuana Metabolites in Urine by Immunoassay and GC-MS Those numbers apply to people without a buildup of THC in their fat stores.
Frequent users face a very different situation. One study comparing infrequent and frequent cannabis users found that the last positive urine specimen appeared after about 4 days in infrequent users (at the standard 15 ng/mL THC-COOH cutoff) but after 17 days in frequent users at the same cutoff. At a lower cutoff of about 10 ng/mL, frequent users tested positive for up to 22 days. Using a broader immunoassay screen at 20 ng/mL, some frequent users still tested positive at 27 days.3Journal of Analytical Toxicology. Urinary Excretion of 11-nor-9-Carboxy-Δ9-Tetrahydrocannabinol and Cannabinoids in Frequent and Infrequent Drug Users In that study, the urinary excretion half-life in frequent users showed terminal values stretching up to about 10 days, which explains why the tail end of detection can drag on so long.
Here is a rough guide by usage pattern for a standard 50 ng/mL immunoassay urine screen:
- Single use: typically 1–3 days
- Occasional use (a few times a month): roughly 3–7 days
- Regular use (several times a week): roughly 1–3 weeks
- Daily heavy use: potentially 3–4+ weeks, sometimes longer
Blood Tests
Blood testing is less common for employment screening but shows up in legal settings, particularly in driving-under-the-influence cases. Blood tests detect the parent THC molecule (not just the metabolite), so they have a much shorter window for detecting active impairment. In occasional users, THC in blood drops below detectable levels within hours to a day or two after a single session.
Heavy daily smokers are a different story. In a clinical study where chronic daily cannabis smokers were admitted to a research ward and monitored, most were THC-positive in blood on arrival, and THC decreased gradually over weeks. Two out of five participants still had detectable blood THC at 30 days. The metabolite THC-COOH persisted even longer: four out of five participants remained THC-COOH positive after 30 days, and one person was still positive on discharge at 33 days.4PubMed Central. Impact of prolonged cannabinoid excretion in chronic daily cannabis smokers’ blood on per se drugged driving laws For jurisdictions that set legal thresholds for blood THC concentration while driving, this is a real problem: someone who hasn’t used cannabis in weeks can still exceed a per se limit.
Blood THC-COOH levels can also be used to infer usage patterns. Concentrations above 75 ng/mL in a routine blood draw are associated with regular cannabis use, while levels below 5 ng/mL suggest occasional use.5Therapeutic Drug Monitoring. Review of Biologic Matrices (Urine, Blood, Hair) as Indicators of Recent or Ongoing Cannabis Use
Saliva and Oral Fluid Tests
Oral fluid (saliva) testing is growing in popularity for roadside drug testing and some workplace programs because collection is easy and hard to fake. But the detection window is relatively short compared to urine. In a controlled smoking study, all oral fluid specimens were THC-positive for up to about 13.5 hours after smoking, with no major difference between frequent and occasional smokers in the first 30 hours.6PubMed Central. Oral fluid cannabinoid concentrations following controlled smoked cannabis in chronic frequent and occasional smokers However, using a more sensitive confirmation method looking for THC-COOH in oral fluid extended the detection window to over 22 hours, longer than many earlier estimates suggested.7Clinical Chemistry. On-Site Test for Cannabinoids in Oral Fluid
One thing to understand about saliva tests is that right after smoking, THC concentrations in oral fluid can spike above 1,000 µg/L because of direct contamination of the mouth by smoke. That number falls off rapidly, so saliva tests are best at catching very recent use rather than use from days ago.8PubMed Central. Current knowledge on cannabinoids in oral fluid For most people, the practical detection window for saliva is somewhere around 24 to 72 hours after last use, depending on how the test is configured and how heavily you consumed.
Hair Follicle Tests
Hair testing has the longest detection window of any standard method. The typical protocol examines the 1.5 inches of hair closest to the scalp, which represents roughly 90 days of growth. But the science behind cannabis hair testing is surprisingly controversial. A study involving controlled oral THC administration found THC-COOH in hair segments corresponding to time periods well before the participant actually started taking THC, suggesting that sweat and sebum on the scalp can carry the metabolite along the hair shaft and deposit it in older segments.9Scientific Reports. Finding cannabinoids in hair does not prove cannabis consumption In beard hair, THC-COOH was detected up to 11 weeks after the last intake.
Further complicating things, research has shown that one key cannabis compound found in hair (THCA-A) gets there almost entirely through external contamination, like sidestream smoke, rather than from internal metabolism.10Forensic Science International. Hair analysis for Δ9-tetrahydrocannabinolic acid A—New insights into the mechanism of drug incorporation of cannabinoids into hair This means a positive hair test doesn’t necessarily prove you consumed cannabis yourself. For this reason, hair testing is sometimes viewed skeptically in legal proceedings, though it remains widely used in employment screening.
Smoking Versus Edibles
How you consume THC changes both the intensity of the high and how your body processes the drug. When you smoke or vape, THC enters your bloodstream almost instantly through the lungs, producing a sharp peak in blood levels followed by a relatively quick decline. When you eat an edible, absorption is slow and erratic. After ingesting a cannabis brownie containing 20 mg of THC, peak blood THC concentrations were dramatically lower than those seen after smoking, and the overall bioavailability was only around 6%.11Clinical Chemistry. Cannabis Edibles: Blood and Oral Fluid Cannabinoid Pharmacokinetics and Evaluation of Oral Fluid Screening Devices for Predicting Δ9-Tetrahydrocannabinol in Blood and Oral Fluid following Cannabis Brownie Administration Cannabinoid levels in blood and oral fluid after oral consumption were consistently low compared to inhalation.12PubMed Central. Pharmacokinetic Profile of Oral Cannabis in Humans: Blood and Oral Fluid Disposition and Relation to Pharmacodynamic Outcomes
What does that mean for detection? Lower peak blood levels from edibles generally mean shorter detection windows in blood and saliva. But much of the THC from an edible gets processed by the liver before reaching the rest of your body, producing higher relative amounts of the THC-COOH metabolite that urine tests target. So the route of consumption can shift which test type catches you and for how long, though use frequency still dominates the overall detection timeline.
The Fat Storage Problem
THC’s affinity for fat is the single biggest reason it sticks around longer than almost any other recreational drug. If you have more body fat, you have more tissue for THC to hide in. And once it’s stored, it doesn’t just sit there permanently; it slowly leaks back into your bloodstream as fat cells turn over and release their contents.
Animal research has shown that this release can be amplified by anything that promotes fat breakdown. In rats chronically exposed to THC, both fasting and exercise caused measurable bumps in blood THC-COOH levels after a washout period.13PubMed. Fasting and exercise increase plasma cannabinoid levels in THC pre-treated rats: an examination of behavioural consequences Human data aligns with this, though the effect is modest for most people. In a study of regular cannabis users, exercise produced an average 25% increase in serum THC and a 7% bump in THC-COOH. In one individual, the increase was close to a doubling.14PubMed Central. Can Physical Exercise or Food Deprivation Cause Release of Fat-Stored Cannabinoids? Food deprivation caused similar but somewhat smaller changes.
This matters practically: crash-dieting or intense exercise right before a drug test could temporarily raise your THC metabolite levels, not lower them. The folk wisdom that “sweating it out” helps you pass a test faster is, at best, oversimplified. Over a long enough period, burning fat should eventually deplete those stores, but in the short term around a test date, it can work against you.
Do Detox Drinks and Dilution Methods Work?
The internet is full of products and protocols claiming to flush THC from your system. Most rely on a single principle: dilution. If you drink a large volume of fluid before a urine test, your urine becomes watered down, and the concentration of THC-COOH may temporarily drop below the test’s cutoff. Research confirms that excessive fluid intake does produce specimens with creatinine levels below 20 mg/dL and specific gravity below 1.003, markers of a diluted sample, within roughly 1.5 to 2 hours after drinking.15PubMed. In vivo adulteration: excess fluid ingestion causes false-negative marijuana and cocaine urine test results
The catch: testing labs know this. Routine specimen integrity checks look at creatinine, pH, temperature, and specific gravity. A flagged specimen is usually treated as a refusal to test. Some commercial adulterant products have been able to avoid those routine integrity checks, but labs are continually updating their protocols.16American Journal of Clinical Pathology. The Effects of Adulterants and Selected Ingested Compounds on Drugs-of-Abuse Testing in Urine In practice, dilution strategies are a gamble: they can produce a “dilute negative” result, which some employers accept but many require a retest. The only sure way to test clean is to have actually cleared enough THC-COOH from your body, which is a function of time and your personal physiology.
Genetics and Individual Variation
Your liver breaks down THC primarily using enzymes from the CYP2C and CYP3A families. People carry different genetic variants of these enzymes, and those variants can change how quickly THC is metabolized. Lab studies have shown that certain common CYP2C9 variants (called CYP2C9.2 and CYP2C9.3) process THC at only about 30% the rate of the normal version.17Biochemical Pharmacology. CYP2C-catalyzed delta(9)-tetrahydrocannabinol metabolism: Kinetics, pharmacogenetics and interaction with phenytoin In theory, a person carrying these slower variants would clear THC more slowly and potentially test positive longer. In practice, however, a recent human study looking at CYP2C9 and CYP2C19 genotypes after controlled cannabis consumption found only slight trends and no statistically significant differences in blood THC concentrations across predicted phenotypes.18PubMed Central. Assessing the influence of CYP2C9 and CYP2C19 genotypes on the metabolism of CBD-cannabis after controlled single and repetitive consumption The study was small and retrospective, so it’s possible the effect is real but modest enough to be hard to measure in everyday conditions.
Beyond genetics, certain medications can change how fast your liver processes THC. Strong inhibitors of the CYP3A4 enzyme, like the heart drug verapamil or the antibiotic clarithromycin, can raise blood levels of THC and its active metabolite. Conversely, strong CYP3A4 inducers like the antibiotic rifampicin or the seizure medication carbamazepine can speed up THC clearance and lower blood levels.19PubMed Central. Drug Interactions of Tetrahydrocannabinol and Cannabidiol in Cannabinoid Drugs If you take any of these medications, your clearance timeline could shift meaningfully in either direction.
Will Delta-8 THC or CBD Cause a Positive Test?
Standard urine drug screens use immunoassays designed to detect metabolites of delta-9-THC, but these assays are not perfectly specific. Delta-8-THC, which has surged in popularity as a legally gray alternative to delta-9, produces a metabolite (11-nor-9-carboxy-delta-8-THC) that triggers positive results on all six major commercially available immunoassay platforms.20Journal of Analytical Toxicology. The cross-reactivity of cannabinoid analogs (delta-8-THC, delta-10-THC and CBD), their metabolites and chiral carboxy HHC metabolites in urine of six commercially available homogeneous immunoassays Delta-10-THC analogs also cross-react with most (though not all) of those same assays. Confirmatory testing using mass spectrometry can tell the two apart, but many standard workplace panels only confirm the presence of THC-COOH in general terms. In a clinical case series, children exposed to delta-8-THC all tested positive on standard urine drug screens, and only specialized confirmatory testing revealed that the metabolites were actually from delta-8 rather than delta-9.21PubMed Central. Delta-8-Tetrahydrocannabinol Exposure and Confirmation in Four Pediatric Patients
CBD is a different story. Pure CBD and its metabolites did not cross-react with any of the six immunoassay kits tested, even at concentrations 20 times higher than the standard cutoff.20Journal of Analytical Toxicology. The cross-reactivity of cannabinoid analogs (delta-8-THC, delta-10-THC and CBD), their metabolites and chiral carboxy HHC metabolites in urine of six commercially available homogeneous immunoassays However, many commercially sold CBD products contain trace amounts of delta-9-THC, which can accumulate with heavy daily use. A controlled study found that at THC concentrations typical of current hemp oil products, positive immunoassay results at the 50 ng/mL cutoff were extremely rare (under 0.2% detection rate). But hemp products with higher THC concentrations produced positive results 23–46% of the time.22Clinical Chemistry. Urinary Cannabinoid Detection Times after Controlled Oral Administration of Δ9-Tetrahydrocannabinol to Humans So if you use CBD products and face drug testing, the risk comes from the THC contamination in the product itself, not from the CBD molecule.
Can Secondhand Smoke Make You Fail?
This is one of the most common questions people have, and the honest answer is: under normal circumstances, no. But under extreme conditions, it’s technically possible. Researchers tested non-smokers who sat in an unventilated room while others smoked cannabis. Exposure under those enclosed, smoky conditions did produce detectable cannabinoid levels in the non-smokers’ blood and urine. One urine specimen even tested positive at the standard 50 ng/mL cutoff, and several tested positive at the lower 20 ng/mL cutoff.23Drug and Alcohol Dependence. Non-smoker exposure to secondhand cannabis smoke II: Effect of room ventilation on the physiological, subjective, and behavioral/cognitive effects But these positive tests were limited to the hours immediately after exposure and occurred only when the conditions were essentially a hotbox with no ventilation.24PubMed Central. Non-Smoker Exposure to Secondhand Cannabis Smoke. I. Urine Screening and Confirmation Results
In a normally ventilated room, casual proximity to someone smoking cannabis is extremely unlikely to produce a positive drug test at any standard cutoff. The secondhand-smoke defense for a failed drug test is plausible only under conditions that would be obvious to everyone involved: a sealed car, an enclosed room thick with smoke, extended exposure time.
Chronic Users and Pharmacokinetic Modeling
Researchers have developed computer models that try to predict blood THC levels by factoring in age, sex, body composition, bioavailability, and genetic enzyme variants.25Computers & Chemical Engineering. Physiologically-based pharmacokinetic model for predicting blood and tissue tetrahydrocannabinol concentrations These models confirm what the clinical data shows: the single strongest predictor of how long THC stays detectable is usage frequency. Chronic consumers not only accumulate more THC in fat stores, they also show greater bioavailability per dose. One pharmacokinetic modeling study found that chronic cannabis users had about 2.4 times greater bioavailability than occasional users for the same dose, leading to higher peak and cumulative concentrations of THC and its metabolites.26PubMed. Population pharmacokinetic model of blood THC and its metabolites in chronic and occasional cannabis users and relationship with on-site oral fluid testing
This helps explain why a heavy daily user can test positive for THC in blood for nearly a month after quitting, as documented in the clinical ward study mentioned earlier where participants were monitored continuously.4PubMed Central. Impact of prolonged cannabinoid excretion in chronic daily cannabis smokers’ blood on per se drugged driving laws The combination of saturated fat stores and higher absorption efficiency creates a pharmacological snowball effect that takes significant time to unwind.
Low-Dose Hemp Products and Accidental Positives
Since the 2018 Farm Bill legalized hemp containing less than 0.3% THC by dry weight, many people consume hemp-derived products and wonder whether these tiny THC amounts can accumulate enough to trigger a drug test. Research involving consumption of truly low-dose hemp oil found no detectable THC in oral fluid, blood, or urine at any time point. Only trace amounts of the metabolite THC-COOH appeared in blood and urine four hours after taking the higher of the two low doses tested.27Forensic Science International. Detection of delta-9-tetrahydrocannabinol (THC) in oral fluid, blood and urine following oral consumption of low-content THC hemp oil At concentrations typical of properly manufactured hemp oil, the chance of a positive urine immunoassay at the 50 ng/mL cutoff was essentially zero.22Clinical Chemistry. Urinary Cannabinoid Detection Times after Controlled Oral Administration of Δ9-Tetrahydrocannabinol to Humans
The real-world risk comes from mislabeled or poorly regulated products. Independent lab analyses have repeatedly found that some hemp-derived CBD oils, gummies, and vape cartridges contain significantly more THC than their labels claim. If you’re subject to drug testing and use hemp products regularly, that labeling uncertainty is the threat, not the pharmacology of low-dose hemp itself.